3-[3-(1-Methylpiperidin-4-yl)propoxy]propionitrile, 1g

3-methyl-5-(trifluoromethyl)-4H-1,2,4-triazole, 95%, 500mg

1,3-Diamino-2-hydroxypropane, 97.0%, 1kg

2-(1-Cyclopenten-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 10g

(S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-(2,6-difluorophenyl)propanoic acid, 98%, 1g

n-[(2-chloro-6-fluorophenyl)methyl]-2,3-dimethylcyclohexan-1-amine hydrochloride, 97%, 100mg

N-(2-methoxy-5-morpholinophenylcarbamothioyl)benzamide, 98%, 250mg

1-(Isocyano(tosyl)methyl)-3-(trifluoromethyl)benzene, 95.0%, 1g

1-(4-Nitrophenyl)piperidine, 97.0%, 10g

4-(2-Hydroxy-ethoxy)-piperidine-1-carboxylic acid tert-butyl ester, 1g

GC capillary column ROTI®Cap-5 MS Ultra, 30 m, 0.32 mm, 0.25 µm, 1 Piece(s)

(S)-1-(3-Trifluoromethylphenyl)ethanol, 97%, 100mg

(4-BROMOTHIAZOL-2-YL)METHANAMINE HCL, 95.0%, 500mg